# FDA 483 - Unilever Manufacturing (US), Inc. - September 15, 2025

Source: https://www.keypedia.com/records/483/unilever-manufacturing-us-inc/6484c3b4-13a5-4381-8634-48dfc2fcef3e

> FDA 483 for Unilever Manufacturing (US), Inc. on September 15, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Unilever Manufacturing (US), Inc.
- Inspection Date: 2025-09-15
- Product Type: drugs
- Office Name: Dallas District Office
- Summary: The FDA inspected Unilever Manufacturing (US), Inc. in Jonesboro, AR, an OTC drug manufacturer. The inspection revealed significant deficiencies in the firm's quality system and laboratory controls, including inadequate investigations into out-of-specification results, lack of quality unit oversight for procedures and change control, and issues with stability sample storage and microbiology testing methods. These findings indicate a lack of robust controls over critical manufacturing and testing processes.

## Related Documents

- [483 - 2020-03-10](https://www.keypedia.com/records/483/unilever-manufacturing-us-inc/ea9a9dcc-f342-4bfa-a8b8-37e7301b3a01)

## Related Officers

- [Thuy Tram L. Nguyen](https://www.keypedia.com/people/thuy-tram-l-nguyen/b58f2445-728e-4f79-b7eb-4dfb7e982e25)

Company: https://www.keypedia.com/companies/unilever-manufacturing-us-inc/ae587d51-1cf8-4ced-af22-8da0d2758cf6

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9